N-Cinnamoyl-3-Methoxyaniline CAS 127033-74-3 and 7-Hydroxyquinolin-2(1H)-One CAS 70500-72-0 is pharma intermediates of ACTIVE PHARMACEUTICAL INGREDIENT (API) Brexpiprazole. API are having therapeutic application in Anti-Psychotic category.

Brexpiprazole is an atypical antipsychotic. It is a dopamine D₂ receptor partial agonist and has been described as a "serotonin–dopamine activity modulator". It is a medication that works in the brain to treat schizophrenia. It is also known as a second generation antipsychotic (SGA) or atypical antipsychotic. Brexpiprazole rebalances dopamine and serotonin to improve thinking, mood, and behavior.